Cho, Hanna
for the K-ROAD Study Groups
14 papers on CoChatORCID 0000-0001-5936-1546
Most cited papers
- Verified
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
Tsai, J., Lee, J. T., Wang, W., Zhang, J., Cho, H., Mamo, S., Bremer, R., Gillette, S., Kong, J., Haass, N. K., et al. (2008) · Proceedings of the National Academy of Sciences
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 1,346
- Verified
In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum
Cho, H., Choi, J. Y., Hwang, M. S., Kim, Y. J., Lee, H. M., Lee, H. S., Lee, J. H., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2016) · Annals of Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 499
- Verified
Discriminative Accuracy of [ 18 F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
Ossenkoppele, R., Rabinovici, G. D., Smith, R., Cho, H., Schöll, M., Strandberg, O., Palmqvist, S., Mattsson, N., Janelidze, S., Santillo, A., et al. (2018) · JAMA
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 472
- Verified
Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development
Donovan, K. A., Ferguson, F. M., Bushman, J. W., Eleuteri, N. A., Bhunia, D., Ryu, S., Tan, L., Shi, K., Yue, H., Liu, X., et al. (2020) · Cell
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 359
- Verified
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging
Ossenkoppele, R., Smith, R., Mattsson-Carlgren, N., Groot, C., Leuzy, A., Strandberg, O., Palmqvist, S., Olsson, T., Jögi, J., Stormrud, E., et al. (2021) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 311
- Verified
Assessment of demographic, genetic, and imaging variables associated with brain resilience and cognitive resilience to pathological tau in patients with Alzheimer disease
Ossenkoppele, R., Lyoo, C. H., Jester-Broms, J., Sudre, C. H., Cho, H., Ryu, Y. H., Choi, J. Y., Smith, R., Strandberg, O., Palmqvist, S., et al. (2020) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 161
- Verified
Subcortical 18F‐AV‐1451 binding patterns in progressive supranuclear palsy
Cho, H., Choi, J. Y., Hwang, M. S., Lee, S. H., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2017) · Movement Disorders
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 119
- Verified
Structural Brain Changes after Traditional and Robot-Assisted Multi-Domain Cognitive Training in Community-Dwelling Healthy Elderly
Kim, G. H., Jeon, S., Im, K., Kwon, H., Lee, B. H., Kim, G. Y., Jeong, H., Han, N. E., Seo, S. W., Cho, H., et al. (2015) · PLOS ONE
Dementia and Cognitive Impairment ResearchCognitive Abilities and Testing
Cited by 101
- Verified
Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study
Cho, H., Choi, J. Y., Lee, H. S., Lee, J. H., Ryu, Y. H., Lee, M. S., Jack, C. R., & Lyoo, C. H. (2019) · Journal of Nuclear Medicine
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 94
- Verified
Clinical effect of white matter network disruption related to amyloid and small vessel disease
Kim, H. J., Im, K., Kwon, H., Lee, J.-M., Kim, C., Kim, Y. J., Jung, N.-Y., Cho, H., Ye, B. S., Noh, Y., et al. (2015) · Neurology
Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research
Cited by 85
- Verified
Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease
Cho, H., Choi, J. Y., Lee, S. H., Lee, J. H., Choi, Y.-C., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2017) · Neurobiology of Aging
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 83
- Verified
Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia
Ye, B. S., Seo, S. W., Kim, J.-H., Kim, G. H., Cho, H., Noh, Y., Kim, H. J., Yoon, C. W., Woo, S.-Y., Kim, S. H., et al. (2015) · Neurology
Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments
Cited by 67
- Verified
Biomarkers of neurodegeneration across the Global South
McGlinchey, E., Duran-Aniotz, C., Akinyemi, R., Arshad, F., Zimmer, E. R., Cho, H., Adewale, B. A., & Ibanez, A. (2024) · The Lancet Healthy Longevity
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 32
- Verified
Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and Anemia
Yun, J., Lee, J., Shin, D., Lee, E. H., Kim, J. P., Ham, H., Gu, Y., Chun, M. Y., Kang, S. H., Kim, H. J., et al. (2026) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free